AEON Biopharma Inc - Class A

Research AEON Biopharma Inc - Class A (AEON) on Bullrun: market cap USD 19.46M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerAEON
• ExchangeNYSE MKT
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 19.46M
• Financial periodFY2025
• Net income-USD 39.22M
• Free cash flow-USD 17.31M

Valuation Snapshot

latest market cap is USD 19.46M.

About AEON Biopharma Inc - Class A

AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of chronic and episodic migraine. It also develops ABP-450 for the treatment of gastroparesis and post-traumatic stress disorder.

Frequently asked questions

What is AEON Biopharma Inc - Class A's market cap?

AEON Biopharma Inc - Class A's market capitalization is USD 19.46M.

What does AEON Biopharma Inc - Class A do?

AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for...